Antipsychotic medication side effect assessment tools: A systematic review

Norman Jay Stomski, Paul Morrison, Amanda Meyer

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Objective: The aim of this systematic review was to critically appraise the psychometric properties of antipsychotic medication side effect assessment tools. Methods: Systematic searches were undertaken in PubMed, CINAHL and CENTRAL from inception to October 2014. Studies were included if they detailed the evaluation of psychometric properties of antipsychotic medication side effect assessment tools in mental health populations. Studies were excluded if they examined the use of antipsychotic medication side effect assessment tools in non-mental health populations, including people suffering from dementia, Parkinsonism and Alzheimer's. Narrative reviews and studies published in any language other than English were also excluded. Results: Content validity was appropriately established for only one of the tools, reliability was inappropriately evaluated for all but one tool, and the assessment of responsiveness was not acceptable for any tool. Conclusion: Further psychometric studies are warranted to consolidate the psychometric properties of the included antipsychotic medication side effect assessment tools before any of these tools can be confidently recommended for either research or clinical purposes.

Original languageEnglish
Pages (from-to)399-409
Number of pages11
JournalAustralian and New Zealand Journal of Psychiatry
Volume50
Issue number5
DOIs
Publication statusPublished - 2015
Externally publishedYes

Fingerprint

Psychometrics
Antipsychotic Agents
Parkinsonian Disorders
PubMed
Reproducibility of Results
Population
Mental Health
Alzheimer Disease
Language
Health
Research

Cite this

@article{c45ed6be16f44e6ebe8e4c7b3a11a4ff,
title = "Antipsychotic medication side effect assessment tools: A systematic review",
abstract = "Objective: The aim of this systematic review was to critically appraise the psychometric properties of antipsychotic medication side effect assessment tools. Methods: Systematic searches were undertaken in PubMed, CINAHL and CENTRAL from inception to October 2014. Studies were included if they detailed the evaluation of psychometric properties of antipsychotic medication side effect assessment tools in mental health populations. Studies were excluded if they examined the use of antipsychotic medication side effect assessment tools in non-mental health populations, including people suffering from dementia, Parkinsonism and Alzheimer's. Narrative reviews and studies published in any language other than English were also excluded. Results: Content validity was appropriately established for only one of the tools, reliability was inappropriately evaluated for all but one tool, and the assessment of responsiveness was not acceptable for any tool. Conclusion: Further psychometric studies are warranted to consolidate the psychometric properties of the included antipsychotic medication side effect assessment tools before any of these tools can be confidently recommended for either research or clinical purposes.",
keywords = "antipsychotic medication, assessment tool, side effect, Systematic review",
author = "Stomski, {Norman Jay} and Paul Morrison and Amanda Meyer",
year = "2015",
doi = "10.1177/0004867415608244",
language = "English",
volume = "50",
pages = "399--409",
journal = "Australian & New Zealand Journal of Psychiatry",
issn = "0004-8674",
publisher = "SAGE Publications Ltd",
number = "5",

}

Antipsychotic medication side effect assessment tools : A systematic review. / Stomski, Norman Jay; Morrison, Paul; Meyer, Amanda.

In: Australian and New Zealand Journal of Psychiatry, Vol. 50, No. 5, 2015, p. 399-409.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Antipsychotic medication side effect assessment tools

T2 - A systematic review

AU - Stomski, Norman Jay

AU - Morrison, Paul

AU - Meyer, Amanda

PY - 2015

Y1 - 2015

N2 - Objective: The aim of this systematic review was to critically appraise the psychometric properties of antipsychotic medication side effect assessment tools. Methods: Systematic searches were undertaken in PubMed, CINAHL and CENTRAL from inception to October 2014. Studies were included if they detailed the evaluation of psychometric properties of antipsychotic medication side effect assessment tools in mental health populations. Studies were excluded if they examined the use of antipsychotic medication side effect assessment tools in non-mental health populations, including people suffering from dementia, Parkinsonism and Alzheimer's. Narrative reviews and studies published in any language other than English were also excluded. Results: Content validity was appropriately established for only one of the tools, reliability was inappropriately evaluated for all but one tool, and the assessment of responsiveness was not acceptable for any tool. Conclusion: Further psychometric studies are warranted to consolidate the psychometric properties of the included antipsychotic medication side effect assessment tools before any of these tools can be confidently recommended for either research or clinical purposes.

AB - Objective: The aim of this systematic review was to critically appraise the psychometric properties of antipsychotic medication side effect assessment tools. Methods: Systematic searches were undertaken in PubMed, CINAHL and CENTRAL from inception to October 2014. Studies were included if they detailed the evaluation of psychometric properties of antipsychotic medication side effect assessment tools in mental health populations. Studies were excluded if they examined the use of antipsychotic medication side effect assessment tools in non-mental health populations, including people suffering from dementia, Parkinsonism and Alzheimer's. Narrative reviews and studies published in any language other than English were also excluded. Results: Content validity was appropriately established for only one of the tools, reliability was inappropriately evaluated for all but one tool, and the assessment of responsiveness was not acceptable for any tool. Conclusion: Further psychometric studies are warranted to consolidate the psychometric properties of the included antipsychotic medication side effect assessment tools before any of these tools can be confidently recommended for either research or clinical purposes.

KW - antipsychotic medication

KW - assessment tool

KW - side effect

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=84964292252&partnerID=8YFLogxK

U2 - 10.1177/0004867415608244

DO - 10.1177/0004867415608244

M3 - Review article

VL - 50

SP - 399

EP - 409

JO - Australian & New Zealand Journal of Psychiatry

JF - Australian & New Zealand Journal of Psychiatry

SN - 0004-8674

IS - 5

ER -